Feedback / Questions
Proellex-V (telapristone suppository) - Repros
Repros Therapeutics Inc- Corporate Update
(Repros)
-
Sep 8, 2011 -
Repros has submitted IND application with FDA for vaginal administration in the treatment of uterine fibroids
IND submission
http://reprosrx.com/documents/Corporate-Update.pdf
Sep 8, 2011
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious